Dual‐targeting therapy against HER3/MET in human colorectal cancers

BACKGROUND: Colorectal cancer (CRC) is the most common malignancy in the world, and novel molecular targeted therapies for CRC have been vigorously pursued. We searched for novel combination therapies based on the expression patterns of membrane proteins in CRC cell lines. RESULTS: A positive correl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamasaki, Akitaka, Miyake, Rikuto, Hara, Yuta, Okuno, Hideki, Imaida, Takuya, Okita, Kouki, Okazaki, Shogo, Akiyama, Yasutoshi, Hirotani, Kenji, Endo, Yuichi, Masuko, Kazue, Masuko, Takashi, Tomioka, Yoshihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166911/
https://www.ncbi.nlm.nih.gov/pubmed/36751113
http://dx.doi.org/10.1002/cam4.5673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166911/
https://www.ncbi.nlm.nih.gov/pubmed/36751113
http://dx.doi.org/10.1002/cam4.5673

Ejemplares similares